AstraZeneca Plans to Construct New R&D Center in the US
AstraZeneca has announced its plans to construct a new research and development site in Cambridge, Massachusetts. The new facility will [...]
ICER Releases Draft Evidence Report for AstraZeneca’s Asthma Drug
The Institute for Clinical and Economic Review (ICER) recently published its draft evidence report for asthma drug tezepelumab. The monoclonal [...]
Oxford/AstraZeneca Scientists Discuss Rethinking Vaccine Development During the COVID-19 Pandemic
The team of scientists and managers responsible for the Oxford/AstraZeneca vaccine against COVID-19 discuss how the extraordinary circumstances in which [...]
ICER Will Consider AstraZeneca Asthma Treatment
The Institute for Clinical and Economic Review (ICER) is set to evaluate AstraZeneca’s tezepelumab. ICER will consider the efficacy and [...]
FDA Approved NDA for KOSELUGO™ (selumetinib)
Recently the FDA approved AstraZeneca’s KOSELUGO™ (selumetinib) for treatment of pediatric patients two years of age and older with neurofibromatosis [...]
AstraZeneca Reaches $750 Million Deal to Support COVID-19 Vaccine
AstraZeneca reached a $750 million deal with the Coalition for Epidemic Preparedness Innovations (CEPI) and the Gavi Vaccine Alliance as [...]
Trump Administration Picks Five Companies in Operation Warp Speed
The Trump administration has selected five drugmakers as being most likely to develop a coronavirus vaccine, The New York Times [...]
